Gerard T. Harty
Gerard T. Harty publishes mostly in Pathology and Forensic Medicine, Oncology and Economics and Econometrics, on topics such as Multiple Sclerosis Research Studies, Polyomavirus and related diseases and Health Systems, Economic Evaluations, Quality of Life.
- World rank
- #3,308,169 of 7,710,434 ranked researchers
- Rank in United States
- #934,665 of 1,627,098
- Works
- 36
- Citations
- 315
- Citations per work
- 8.8
What does Gerard T. Harty research?
Gerard T. Harty's work is mostly in Medicine (58%), Economics, Econometrics and Finance (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2157.8%
- Medicine2157.8%
- Everything else1131.1%
- Social Sciences411.1%
- 1Pathology and Forensic Medicine23% of their works
- 2Oncology14% of their works
- 3Economics and Econometrics11% of their works
- 4Neurology8% of their works
- 5Hematology7% of their works
- 6Public Health, Environmental and Occupational Health6% of their works
Research topics
- Multiple Sclerosis Research Studies
- Polyomavirus and related diseases
- Health Systems, Economic Evaluations, Quality of Life
- Multiple Myeloma Research and Treatments
- Chronic Lymphocytic Leukemia Research
- Amyotrophic Lateral Sclerosis Research
- Acute Lymphoblastic Leukemia research
- Fungal Plant Pathogen Control
Which keywords describe Gerard T. Harty's research?
The keywords of their largest research topics: Diagnostic Criteria, Multiple Sclerosis, Minimal Residual Disease, Prognostic Factors, Merkel Cell Carcinoma, Polyomavirus, Cost-effectiveness Analysis and Quality of Life.
- Plant Pathogens
- TDP-43
- FUS/TLS
- Childhood Cancer
- International Myeloma Working Group
- Quality of Life
- Polyomavirus
- Prognostic Factors
- Multiple Sclerosis
- Diagnostic Criteria
- Minimal Residual Disease
- Merkel Cell Carcinoma
- Cost-effectiveness Analysis
- Diagnosis Criteria
- Acute Lymphoblastic Leukemia
- Chronic Lymphocytic Leukemia
- Genomic Aberrations
- Fungicide Resistance
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Diagnostic Criteria211 topic
- Multiple Sclerosis211 topic
- Minimal Residual Disease92 topics
- Prognostic Factors82 topics
- Merkel Cell Carcinoma71 topic
- Polyomavirus71 topic
- Cost-effectiveness Analysis61 topic
- Quality of Life61 topic
- Diagnosis Criteria51 topic
- International Myeloma Working Group51 topic
- Acute Lymphoblastic Leukemia41 topic
- Childhood Cancer41 topic
- Chronic Lymphocytic Leukemia41 topic
- FUS/TLS41 topic
- Genomic Aberrations41 topic
- TDP-4341 topic
- Fungicide Resistance31 topic
- Plant Pathogens31 topic
Where does Gerard T. Harty work?
Gerard T. Harty's main affiliation in the publication record is Ono Pharmaceutical (United States), United States.
How many publications and citations does Gerard T. Harty have?
OpenAlex counts 36 works and 315 citations for Gerard T. Harty, an h-index of 9, ranking #3,308,169 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Gerard T. Harty. Posts are plain text and can be reported.